[HTML][HTML] Amyloidosis and COVID-19: experience from an amyloid program in Canada
E Lewis, N Fine, RJH Miller, C Hahn, S Chhibber… - Annals of …, 2022 - Springer
Severe acute respiratory syndrome coronavirus (SARS-CoV2) and associated COVID-19
infection continue to impact patients globally. Patients with underlying health conditions are at …
infection continue to impact patients globally. Patients with underlying health conditions are at …
Utility of neuropathy screening for wild-type transthyretin amyloidosis patients
A Russell, C Hahn, S Chhibber, L Korngut… - Canadian Journal of …, 2021 - cambridge.org
Background:Wild-type transthyretin amyloidosis (wtATTR) is an important cause of heart
failure (HF); however, the prevalence and clinical significance of neurologic complications …
failure (HF); however, the prevalence and clinical significance of neurologic complications …
Adult MTM1-related myopathy carriers: Classification based on deep phenotyping
…, JD Wittenbach, S de Chastonay, S Chhibber… - Neurology, 2019 - AAN Enterprises
Objective To better characterize adult myotubularin 1 (MTM1)–related myopathy carriers and
recommend a phenotypic classification. Methods This cohort study was performed at the …
recommend a phenotypic classification. Methods This cohort study was performed at the …
Gold Coast criteria expand clinical trial eligibility in amyotrophic lateral sclerosis
…, A Lee, V Hodgkinson, L Korngut, S Chhibber - Muscle & …, 2022 - Wiley Online Library
Introduction/Aims Consensus criteria to formalize the diagnosis of amyotrophic lateral
sclerosis (ALS) and refine clinical trial populations have evolved. The recently proposed Gold …
sclerosis (ALS) and refine clinical trial populations have evolved. The recently proposed Gold …
Real‐world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real‐world study
J Gladstone, S Chhibber, J Minhas… - … : The Journal of …, 2022 - Wiley Online Library
Objective To describe the real‐world treatment persistence (defined as the continuation of
medication for the prescribed treatment duration), demographics and clinical characteristics, …
medication for the prescribed treatment duration), demographics and clinical characteristics, …
A protocol for single nucleus RNA-seq from frozen skeletal muscle
…, S Lee, MD Nguyen, S Chhibber… - Life Science …, 2023 - life-science-alliance.org
Single-cell technologies are a method of choice to obtain vast amounts of cell-specific
transcriptional information under physiological and diseased states. Myogenic cells are resistant …
transcriptional information under physiological and diseased states. Myogenic cells are resistant …
Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti‐muscle specific kinase antibodies
B Beland, C Hahn, K Jamani, S Chhibber… - Muscle & …, 2023 - Wiley Online Library
Introduction/Aims Up to 25% of patients with myasthenia gravis (MG) have refractory disease
despite trials of multiple immunosuppressants. Several case series describe acetylcholine …
despite trials of multiple immunosuppressants. Several case series describe acetylcholine …
[HTML][HTML] Colchicine Myopathy: A Case Series Including Muscle MRI and ABCB1 Polymorphism Data
…, D Ng, K Martens, H Ebadi, S Chhibber… - Frontiers in …, 2019 - frontiersin.org
Colchicine is a medication most commonly used in the treatment of gout and familial
mediterannean fever. A rare complication of therapy is toxicity causing proximal myopathy and …
mediterannean fever. A rare complication of therapy is toxicity causing proximal myopathy and …
[HTML][HTML] Case report: calpainopathy presenting after bone marrow transplantation, with studies of donor genetic content in various tissue types
…, J Leckie, D Fok, RA Wells, S Chhibber… - Frontiers in …, 2021 - frontiersin.org
We present a patient who had two allogeneic bone marrow transplantations for acute
lymphocytic leukemia. She developed slowly progressive limb-girdle weakness in the context of …
lymphocytic leukemia. She developed slowly progressive limb-girdle weakness in the context of …
[HTML][HTML] Pneumothoraces in collagen VI-related dystrophy: a case series and recommendations for management
KL Fraser, S Wong, AR Foley, S Chhibber… - ERJ open …, 2017 - Eur Respiratory Soc
Collagen VI-related dystrophy (collagen VI-RD) is a rare neuromuscular condition caused
by mutations in the COL6A1, COL6A2 or COL6A3 genes. The phenotypic spectrum includes …
by mutations in the COL6A1, COL6A2 or COL6A3 genes. The phenotypic spectrum includes …